CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Ribon Therapeutics is targeting the discovery and development of monoPARP (mono ADP-ribose polymerase) inhibitors to block cancer cells' fundamental ability to survive under stress.
Company (Alive / Active)
Phone: 617-914-8700
99 Hayden Avenue
Lexington, 02421
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Pyridazinones as parp7 inhibitors | Oct 24, 2019 | Dec 22, 2020 | Patent |
| Quinazolinones as parp14 inhibitors | Dec 20, 2018 | Feb 18, 2020 | Patent |
| Pyridazinones as parp7 inhibitors | Apr 29, 2019 | Feb 04, 2020 | Patent |
| Quinazolinones as parp14 inhibitors | Jan 06, 2020 | Application | |
| Screening methods for parp modulators | Apr 29, 2019 | Application |
